ACR 2011: Challenges in Helping Patients Understand Risks and Benefits of Medications [VIDEO]

Article
Conference|American College of Rheumatology

Marcus Owen, MD, practices rheumatology and internal medicine in Nashville, TN. In this video, Dr. Joseph Kim talks with Dr. Owen about what he hopes to take away from this year's ACR conference and also speaks about some of the biggest challenges he faces in helping patients understand risk and benefit of medications.

Marcus Owen, MD, practices rheumatology and internal medicine in Nashville, TN. In this video, Dr. Joseph Kim talks with Dr. Owen about what he hopes to take away from this year's ACR conference and also speaks about some of the biggest challenges he faces in helping patients understand risk and benefit of medications.

This activity is not sanctioned by, nor a part of, the American College of Rheumatology.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Related Content
Semaglutide May Reduce Rates of Diabetic Retinopathy Outcomes | Image Credit: Twitter

Semaglutide May Reduce Rates of Diabetic Retinopathy Outcomes

Connor Iapoce
July 24th 2024
Article
Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 3rd 2024
Podcast
Zafar Gill, MD | Credit: Childrens Hospital Colorado

Study Links Maternal Asthma to Blinding Eye Disease in Premature Infants

Patrick Campbell
July 22nd 2024
Article
Carol Levy, MD | Credit: T1D Exchange

Diabetes Dialogue: Patient Considerations for Inhaled Insulin, with Carol Levy, MD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
June 30th 2024
Podcast
NEPTUNE: Oral Brepocitinib Effective in Non-infectious Uveitis at 24 Weeks

NEPTUNE: Oral Brepocitinib Effective in Non-infectious Uveitis at 24 Weeks

Connor Iapoce
July 20th 2024
Article
Arshad Khanani, MD | Credit: LinkedIn

RHONE-X: 90% of Patients Treated with Faricimab Free from DME at 4 Years

Patrick Campbell
July 19th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.